GlassScriptPhysician profile
Amy H Caldwell
NPI 1649612979
$5,834.18
in general payments reported to CMS, 2019-2025
34 companies · $1,535 in 2025
The $1,535 reported for 2025 was more than what 92% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,378 · 2022: $988 · 2023: $577 · 2024: $1,357 · 2025: $1,535.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,469.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,468.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,477.07 | 2021-2025 | General - Pain Management, Wavewriter Alpha Prime 16 |
| Forte Bio-Pharma LLC | $1,329.87 | 2021-2025 | Prolate, Nalocet, Tanlor |
| Scilex Pharmaceuticals INC. | $966.48 | 2021-2025 | Ztlido |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $352.44 | 2021-2025 | Relistor |
| Abbvie INC. | $272.87 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $166.88 | 2021-2022 | |
| Arbor Pharmaceuticals, INC. | $129.80 | 2021 | |
| Collegium Pharmaceutical, INC. | $100.39 | 2023-2025 | Belbuca |
| Biohaven Pharmaceutical Holding Company LTD. | $85.19 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $76.06 | 2025 | |
| Pfizer INC. | $74.37 | 2022-2025 | |
| Medtronic, INC. | $72.41 | 2024-2025 | Synchromedii, Inceptiv, Intellis Adaptivestim |
| Abbott Laboratories | $61.93 | 2023-2025 | Freestyle Libre 3, Immunalysis Corporation |
| Grt US Holding, INC. | $58.46 | 2021-2022 | |
| Amgen INC. | $58.29 | 2021-2023 | Repatha, Otezla |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $53.94 | 2021 | |
| Protega Pharmaceutials INC | $50.57 | 2023-2024 | Roxybond |
| Biohaven Pharmaceuticals, INC. | $48.16 | 2021 | |
| Novo Nordisk INC | $48.04 | 2022-2023 | Ozempic |
| Biodelivery Sciences International, INC. | $41.41 | 2021 | |
| Pacira Therapeutics, INC. | $39.51 | 2021 | |
| Virtus Pharmaceuticals LLC | $35.50 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $34.36 | 2021-2022 | |
| Averitas Pharma INC. | $27.84 | 2025 | Qutenza |
| Avanos Medical | $24.30 | 2021-2023 | Coolief* Cooled Radiofrequency |
| Almatica Pharma LLC | $22.52 | 2023 | Gralise |
| Nevro Corp. | $20.27 | 2022 | |
| Biotissue Holdings INC. | $19.11 | 2024 | |
| Dexcom, INC. | $17.95 | 2024 | Dexcom G6 Transmitter |
| Astrazeneca Pharmaceuticals LP | $15.12 | 2023 | Breztri |
| Bioventus LLC | $14.61 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $13.69 | 2022 | |
| Valinor Pharma, LLC | $13.51 | 2025 | Movantik |
| Novartis Pharmaceuticals Corporation | $11.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Caldwell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.